Asia-Pacific Banks Brace for Rising Credit Risks Amid Iran Conflict 
Elliott Targets Bio-Rad as Shares Continue to Struggle 
OpenAI Wins Elon Musk Lawsuit as Jury Rejects Claims Over AI Mission 
Applied Materials Forecasts Strong Q3 Revenue as AI Chip Demand Accelerates 
CXMT Forecasts Record Revenue Growth as Global DRAM Prices Surge 
Amazon Faces Class-Action Lawsuit Over Trump Tariff Price Hikes 
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness 
Alphabet Raises Record $3.6 Billion in Yen Bonds to Support AI Expansion 
Samsung Union Talks Enter Final Stage as Strike Threat Looms 
FTC Antitrust Probe Targets Arm Holdings Over Chip Licensing Practices 
Honda Shares Jump as Automaker Forecasts Profit Recovery Despite Historic Loss 
Standard Chartered Appoints Manus Costello as New CFO Amid Leadership Reshuffle 
Warren Buffett and Stephen Curry Charity Dinner Auction Raises $27 Million for Nonprofits 
Berkshire Hathaway Reveals New Stakes in Delta Air Lines and Macy’s Under Greg Abel 
Anthropic Nears $30 Billion Funding Round at $900 Billion Valuation 
BlackRock-Led GCC Infrastructure Partnership Targets $30 Billion Investment 
ALBANY, N.Y., Sept. 21, 2016 -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 first quarter ended August 31, 2016, on Wednesday, October 5, 2016, before the open of the U.S. financial markets.
Management will host a conference call beginning at 8:00am E.T. on October 5 to discuss the results and to answer questions. To participate in the live call by telephone, please call 888-211-0353 and reference the Conference ID: 8618019.
A live webcast and subsequent archived replay of the conference call may be accessed via the investor relations section of the Company's website under "Events & Presentations" at investors.angiodynamics.com/events. To listen to the live webcast, please go to the website 15-minutes prior to its start to register, download and install the necessary audio software.
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at AngioDynamics.com.
Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
Company Contact: AngioDynamics Inc. Caitlin Stefanik (518) 795-1418 [email protected] Investor Relations Contacts: FTI Consulting Jim Polson (312) 553-6730 [email protected], Kotaro Yoshida (212) 850-5690 [email protected] Media Contact: FTI Consulting Kimberly Ha (212) 850-5612 [email protected]
